. The majority of neoplastic lesions are visible endoscopically and therefore targeted biopsies are appropriate for surveillance colonoscopy. To compare three different techniques for surveillance colonoscopy to detect colonic neoplastic lesions in IBD patients: high defi nition (HD), (DCE), or virtual chromoendoscopy (VCE) using iSCAN image enhanced colonoscopy.
INTRODUCTION
Patients with longstanding infl ammatory bowel disease (IBD) have an increased risk of developing colorectal cancer, initially estimated to be 18% at 30 years aft er diagnosis ( 1 ) . Recent studies reported a decline in incidence of colorectal cancer, which could potentially relate to improved control of infl ammation and implementation of dysplasia surveillance programs ( 2 ) .
Surveillance colonoscopy techniques for detection of dysplasia are variable in clinical practice. Standard defi nition white light endoscopy (SD-WLE) with random mucosal biopsies has historically been the most common method of IBD surveillance colonoscopy, but it is time consuming, expensive, and oft en poorly adopted in clinical practice (3) (4) (5) (6) . To increase the detection of neoplastic lesions in patients with IBD, targeted biopsies may be the preferred surveillance method compared with random biopsies ( 7 ) . Studies have shown that dye spraying chromoendoscopy (DCE) with targeted biopsies increases the detection rate of neoplastic lesions (8) (9) (10) . Th e new and advanced endoscopic technologies have markedly improved the resolution of images compared with previous SD-WLE colonoscopies, so dysplasia has become easier to see from the greater image detail.
Th e recent SCENIC consensus considered DCE the most sensitive modality for dysplasia detection in IBD ( 6 ) . For example, data to support DCE was provided by Marion et al. ( 11 ) who reported a follow-up evaluation of 68 patients from 2006 to 2011 with longstanding IBD. However, results from a large, retrospective study have shown that DCE did not increase dysplasia detection compared with WLE with targeted or random biopsies ( 12 ) . A prior study using narrow-banding imaging also did not fi nd a diff erence in detection of dysplasia in DCE compared with HD -WLE (13) (14) (15) .
New chip technologies have markedly improved the resolution of image compared with previous standard defi nition colonoscopies. Th e HD iSCAN (Pentax, Tokyo, Japan) technique is a digital electronic chromoendoscopy method (16) (17) (18) . We conducted a randomized study comparing three diff erent techniques for surveillance colonoscopy to detect colonic neoplastic lesions in IBD patients: HD alone, DCE (with HD scopes), and VCE using iSCAN digital image enhanced HD colonoscopy. Th e study was powered for noninferiority to ascertain if the emerging standard of practice, which is DCE ( 6 ) , can be replaced by other techniques such as VCE. We also used HD-WLE as a comparator to determine whether with improving technology chromoendoscopy is still required. We also aimed to identify the specifi c clinical and endoscopic features of colonic lesions that were predictors of dysplasia in IBD.
METHODS
Th is was a randomized prospective trial conducted at a single large tertiary referral center at the University of Calgary.
Th e Calgary Conjoint Health Services Research Ethics Board of the University of Calgary approved the study. Th e study was registered at ClinicalTrials.gov with identifi cation number: NCT02098798.
IBD patients referred for surveillance colonoscopy were enrolled aft er they provided informed consent between March 2014 and March 2016.
Th e primary outcome of the study was to compare the detection rates of colonic neoplastic lesions in longstanding ulcerative colitis or Crohn's disease with HD+DCE versus HD+VCE. Secondary outcomes included comparison of detection rates of neoplastic lesions in longstanding ulcerative colitis or Crohn's disease with HD alone versus HD +DCE and HD alone versus HD+VCE.
A further study goal included characterisation of endoscopic features of neoplastic colonic lesions detected for prediction of dysplasia. Th ese inclusion criteria were extensive or left sided ulcerative colitis, colonic Crohn's disease, or unclassifi ed colitis involving at least one third of the colonic mucosa (i.e., ileocecal disease alone were not included and these patients did not undergo surveillance in our center), duration of the disease >8 years, or any duration in patients with concomitant diagnosis of primary sclerosing cholangitis, who could enter surveillance irrespective of disease duration. Clinical and endoscopic remission with Mayo total score <3, and a Mayo endoscopic subscore of 1 or 0 (overall Mayo endoscopic score and no segment of colon had Mayo endoscopic score >1), or Harvey-Bradshaw Index <5 and Simple Endoscopic Score of Crohn's disease of ≤4 ( 19, 20 ) .
Patients were excluded if they were pregnant, had active infl ammatory disease, did not have optimal bowel preparation, had coagulopathy, had a known allergy to dye spray, or were unable to provide informed consent.
All patients enrolled were randomly allocated in blocks of four and assigned at a 1:1:1 ratio to undergo colonoscopy with high defi nition WLE (HD-WLE, group A), high defi nition DCE (HD-DCE, group B), or high defi nition VCE (HD-VCE, group C) using a computer generated allocation. Th e randomization was assigned before the colonoscopy by an independent coordinator blinded to the patients' history. Th e patients were randomized consecutively without stratifi cation by presence or absence of primary sclerosing cholangitis, family history, or by gender. Th e diff erent groups of surveillance patients according to surveillance methods are shown in Table 1 . A fl ow diagram of the study is shown in Figure 1 .
Endoscopic assessment
Th e colonoscopies were performed by a single operator (MI) experienced in dye, optical, and digital electronic virtual chromoendoscopy (VCE) and colonic lesions characterisation. Th is ensured uniform application of technique and uniform cognitive skills. Th e histology was assessed by XG, SU, and PM, who were blinded to the endoscopic reports. All the endoscopic procedures were performed using HD+ iSCAN Pentax EC-3490Fi with EPKi 7000 (Pentax) video processor. Th e system consists of three types of algorithms: Surface Enhancement iSCAN 1 (SE) for detection of abnormalities and lesions in the gastrointestinal tract, and Tone Enhancement and Contrast Enhancement iSCAN 2 and 3, for pattern and vascular characterisation. Each of these algorithm sets could be selected by pressing a pre-assigned button on the hand-piece of the scope ( 17, 18 ) .
Quality of bowel preparation was graded using the Ottawa bowel preparation scale defi ned as excellent, good, fair, poor, and inadequate ( 21 ) . Only patients with excellent or good bowel preparation were included in the study. Endoscopic activity of the disease was assessed using the Mayo endoscopic subscore for ulcerative colitis ( 19 ) and Simple Endoscopic Score for Crohn's disease activity ( 22 ) . Th e colonoscope was advanced to the cecum and the colonic mucosa was meticulously washed with the water jet pump. On withdrawal, each segment (cecum, ascending colon, transverse colon, descending-sigmoid, and rectum) was sequentially examined for lesions using HD endoscopic technique for group A, DCE using 0.04% methylene blue or 0.03% of indigo carmine for group B, and VCE in the iSCAN 2 and 3 mode for group C. We detected and characterised lesions on withdrawal aft er dye spraying or aft er turning on iSCAN or with HD-WLE. We did not focus on detection at insertion of the colonoscope, a protocol similar to the Kiesslich et al. ( 8 ) study.
Th e time to withdraw from the cecum to the rectum was measured in each patient in all the diff erent groups.
Biopsy protocol
Mucosal abnormalities were recorded in each group with regard to location (distance from the anus in centimetres), morphology (polypoid or non-polypoid), and size using the Paris classifi cation ( 23 ) . For each lesion, the mucosal pit pattern was characterised using the Kudo pit pattern ( 24 ) . On withdrawal of the colonoscope, targeted biopsy specimens or endoscopic resection specimen from targeted suspicious areas of dysplasia (circumscribed lesions with irregular surface) were obtained. When the colonic lesion was endoscopically resectable, cautery snare polypectomy or endoscopic mucosal resection was performed, and a few histological samples were taken from the perilesional surrounding mucosa to rule out any multifocal dysplasia. Biopsies were taken to assess infl ammatory activity.
Endoscopic characterisation of the colonic lesions
Endoscopic colonic lesions were classifi ed by the Kudo pit pattern and the Paris classifi cation ( 23, 24 ) , and histology was characterised by the Vienna classifi cation (consensus amongst pathologists). Lesions were classifi ed as polypoid and non-polypoid dysplastic lesions, adenocarcinoma, sessile serrated adenomas/, and tubular adenoma in non-colitic areas.
Histopathologic evaluation
Infl ammatory activity in samples of each specimen container was classifi ed into the following categories based on pathology: no infl ammation, mild to moderate infl ammation, or severe infl ammation ( 25 ) . Neoplastic changes were classifi ed with the new modifi ed Vienna classifi cation into hyperplasia, low-grade dysplasia, high-grade dysplasia, or adenocarcinoma in the colitic areas ( Table 2 ). Areas that were suspicious for neoplasia were sent to a second or third experienced pathologist for further review ( 26 ) .
Statistical analysis
Th e study was powered for non-inferiority with a one-way threshold diff erence of rates of 10% in detection of all neoplastic lesions between DCE and VCE arms and assuming a detection rate of 20% for all neoplastic lesions (10% for dysplastic lesions and adenocarcinoma), requiring a sample size of 90 patients in each group for one-tail P <0.025 with 80% power. Th e assumption rates for detection of all neoplastic lesions was based on previous publications (6) (7) (8) 11, 27, 28 ) .
Quantitative variables were expressed as means±s.d.s. Categorical variables were expressed as total number and frequencies (%). Quantitative variables were analyzed using Fisher's Exact test. Th e data were analyzed for the most signifi cant lesions (dysplasia polypoid or non-polypoid or adenocarcinoma) or for all neoplastic lesions (sessile serrated adenoma, tubular adenoma in non-colitic areas, dysplasia, or adenocarcinoma): P values <0.05 were considered statistically signifi cant. Exploratory univariate logistic regression analysis was performed for selecting endoscopic variables associated with the presence of dysplasia or cancer. Th ose features that were significant at the univariate stage were included in a multivariate logistic regression. We included ORs with 95% CIs to quantify the association of the endoscopic fi ndings with dysplasia/cancer Finally, estimates of predictive accuracy were attained using a bootstrapping technique. Training data were derived by randomly sampling from the observations with replacement. Th e test data were the observations not used for training. Th is process was done 500 times, to get estimates of standard error about the validity measures. Th e multivariate model was fi t for each iteration of the bootstrap and predictions were made for the test data. Th is allows for the estimates of accuracy, sensitivity, specifi city, PPV, and NPV and accuracy for characterisation of colonic lesions were calculated for patients in each arm of the surveillance groups, with histology as the gold standard.
Th e analysis was "per protocol" and statistical analysis was performed using the statistical soft ware package SPSS 23.0 (IBM, NY, USA).
RESULTS

Demographics characteristics of the patients
A total of 285 consecutive patients with longstanding IBD who consented to study participation underwent surveillance colonoscopy between March 2014 and March 2016. Fift een patients were excluded because they did not meet the inclusion criteria owing to insuffi cient bowel preparation or active infl ammation ( Figure 1 ) . Th e demographic details of the patients are summarized in Table 1 . was non-inferior to DCE for detection of dysplasia and adenocarcinoma and for all lesions (Fisher's Exact P =0.65 and 0.71); 95% confi dence limits of the rate diff erence for all lesions was −0.29-0.02 establishing non-inferiority of HD compared with DCE (one-way diff erence not crossing the non-inferiority threshold of 0.1, i.e.,10%). HD was non-inferior to VCE for detection of dysplasia and adenocarcinoma and for all lesions (Fisher Exact P =1 and 0.58); 95% confi dence limits of the rate diff erence for all lesions was −0.34-0.07 establishing non-inferiority of HD compared with VCE (one-way diff erence not crossing the non-inferiority threshold of 0.1, i.e., 10%). Dysplasia (polypoid and non-polypoid) and adenocarcinoma detection rates were similar among the three arms of the study ( P =0.84) ( Table 2 ). Non-polypoid dysplasia detection rates were similar in all three groups, but the numbers were small. All lesions, including sessile serrated adenoma, tubular adenoma in non-colitic areas, dysplasia, and adenocarcinoma detection rates were similar among the three arms of the study ( P =0.74). When analyzed by number of patients with dysplasia (polypoid and non-polypoid) and adenocarcinoma ( Table 3 ), the three arms were similar ( P =0.91). When analyzed by number of patients with all lesions, including sessile serrated adenoma, tubular adenoma in non-colitic areas, dysplasia, and adenocarcinoma, the three arms were similar ( P =0.99). VCE was not inferior to DCE in the number of lesions detected ( Table 3 ).
In the DCE group, the fi rst 18 consecutive patients enrolled underwent colonoscopy with 0.04% indigo carmine and the remaining 72 patients with 0.03% methylene blue because the indigo carmine ampules stopped being available in North America.
A total of 270 patients (55% men; age range 20-77 years, median age 49 years) fulfi lled the inclusion criteria and were enrolled in the trial (48% ulcerative colitis, 50.3% Crohn's disease, 1.8% unclassifi ed colitis). Th e disease duration ranged from 2 to 46 years (median disease duration 14.5 years).Twenty-nine (10.7%) patients had a family history of colon cancer and 60 (22.2%) had a personal history of colonic lesions diagnosed at previous colonoscopies ( Table 1 ) . No patients in the study had adverse events such as bleeding, perforation, or death.
Colonic neoplasia detection rates among the different endoscopic procedures group
Out of the 270 patients, 90 patients were enrolled in the HD arm, 90 patients in the DCE arm, and 90 patients in the VCE arm. In the study, 33 sessile serrated adenomas were found in 21 patients (7.7% of patients), 9 tubular adenoma were found in 5 patients in non-colitic areas (1.9% of patients), 49 dysplastic lesions (41 were polypoid and 8 were non-polypoid) were found in 39 patients (14.4% of patients), and adenocarcinoma was found in one patient (0.3% of patients). Th e colonic neoplastic lesions found in each surveillance arm and in each patient cohort are detailed in Tables 2 and 3 .
Th e primary outcome of VCE was non-inferior to DCE for detection of dysplasia and adenocarcinoma and for all lesions (Fisher's Exact P =1 and 0.64); 95% confi dence limits of the rate diff erence for all lesions was −0.17-0.08 establishing non-inferiority of VCE compared with DCE (one-way diff erence not crossing the pre-specifi ed non-inferiority threshold of 0.1, i.e., 10%). HD Regarding characterisation of lesions, the three techniques had similar sensitivity and specifi city to predict histology of colonic lesions (neoplastic versus non-neoplastic; neoplastic included dysplasia, carcinoma, adenoma, and sessile serrated adenoma and non-neoplastic included pseudopolyps and hyperplastic) ( Figures 2 and 3 ) . Th e sensitivity, specifi city, PPV, NPV and accuracy of each technique to predict histological determination of neoplastic lesions were determined. HD had a sensitivity of 91.3%, specifi city of 78.1%, PPV 88.2%, NPV 88.2%, and accuracy 86%. DCE had a sensitivity of 84.6%, specifi city of 79.5%, PPV 70.9%, NPV 88.2%, accuracy 81.4%, and VCE had a sensitivity of 92.3%, specifi city of 62.5%, PPV 73%, NPV 88.2%, and accuracy 78%.
Procedure duration in the different arms of the study
Th e duration of the withdrawal time of colonoscopy in minutes for patients in the HD group was median 15.4 (range 10-22 min), in the DCE was median 16.2 (range 12-35 min), and in the VCE was median 15.3 (range 9-26 min). Th e three-way KruskalWallis rank sum non-parametric test was used to compare the three groups ( P =NS). Random biopsies were not used (apart from infl ammation assessment), which reduced withdrawal time.
Clinical and endoscopic predictors of dysplasia
Th e endoscopic morphologic characteristics and distribution of the lesions are shown in Appendix 1. Among 270 patients, 91 colonic dysplastic lesions and 1 adenocarcinoma were found. Sixty-two were polypoid and 29 were non-polypoid. Most of these lesions (92.3%) had the Kudo pit pattern III-V types.
Results of univariate and multivariate logistic regression analysis
In the univariate analysis, the following were all associated with correct prediction of colonic neoplasia for all the lesions detected: age in years had an odds ratio (OR) of 1.05 (95% CI 1.02-1.08), localization of the lesions in the right colon had an OR of 6.15 (95% CI 3.12-12.12), Kudo pit pattern types IIO, III-IV, and V had an OR of 20.91 (95% CI 9.34-46.7), and Paris Is/Ip classifi cation had an OR of 3.29 (95% CI 1.69-6.38) ( Table 4 ). Proportional multivariate logistic regression model for the prediction of colonic neoplasia was performed for all detected lesions. Endoscopic Kudo pit pattern (OR 21.50; 95% CI 86.5-60.1) and localization of the lesions in the right colon (OR 6.52; 95% CI 1.98-22.5) were strong predictors of colonic neoplasia ( Table 5 ). When we combined these independent variables of predictors of neoplastic histological changes in detected lesions, the overall accuracy was 78% (95% CI 68-88%), sensitivity 82% (95% CI 68-97%), specifi city 68% (95% CI 47-89%), PPV 85% (95% CI 76-95%), and large "real-life" cohort. It is possible that with improvement in resolution of images in endoscopy and expertize in optical diagnosis, the advantage of DCE becomes less apparent, at least for expert operators. Th ere is still confusion and debate regarding whether DCE should be adopted by every endoscopist doing surveillance in IBD ( 29 ) . Th ere are also many unanswered questions despite SCENIC guidelines ( 29 ) . Unfortunately, there are limited prospective studies comparing DCE with currently used advanced technologies such as HD-WLE and VCE. Th e latest generation of colonoscopes have markedly improved the brightness and sharpness of the quality of images, which has increased detection and characterisation of dysplasia more apparent. Th is has enabled greater prediction of the histological nature of the dysplasia, improving the defi nition of margins, and feasibility of local endoscopic resection versus colectomy. Th ese developments have the potential to increase local resection based on characterisation rather than on pan-proctocolectomy (16) (17) (18) .
Previous randomized studies comparing narrow band imaging to HD-WLE colonoscopy have not suggested a benefi t for narrow band imaging to detect more dysplasia in IBD patients ( 6, (13) (14) (15) . Th e new generation of electronic chromoendoscopes are however getting better in brightness and contrast. To our knowledge, this is the fi rst study utilizing the new generation of iSCAN VCE in surveillance IBD patients. We also need to clarify whether DCE can be performed in the community setting or only in IBD centres with expert, dedicated IBD endoscopists. Th e study by Pelise et al. suggested that DCE could be adopted widely for IBD surveillance ( 28, 30 ) . Similarly, we need to determine via multi-operator multicentre studies whether this is also true for HD-WLE (and VCE).
We have used targeted biopsies based on the evidence of previous literature and European Society of Gastrointestinal Endoscopy guidelines (31) (32) (33) . Studies have demonstrated that only one in a thousand random biopsies revealed dysplasia and only ~1-1.5% of all patients undergoing surveillance would not have dysplasia detected if random biopsies were not performed. Spanish centres have reported similar fi ndings following targeted biopsies in the setting of real life practice ( 28 ) . Our previous report of a cohort of 450 IBD patients undergoing surveillance colonoscopy supports the view that targeted biopsy is the preferred surveillance method compared with random biopsies to increase the detection of neoplastic lesions in patients with IBD ( 34 ). Th is study had suggested that targeted biopsies alone may be suffi cient for HD-WLE, DCE, and VCE but not for SD-WLE ( 34 ). Also in SCENIC's recent statement of replacing random by targeted biopsies, 85% of the NPV 64% (95% CI 42-86%) when referenced against the histology of these detected lesions (the gold standard).
DISCUSSION
In our randomized trial we did not demonstrate a statistical diff erence between HD, VCE, and DCE in the detection rate of colonic dysplastic lesions in IBD patients. We have demonstrated that the neoplasia detection rate of targeted biopsies was similar among the three arms of the study: HD, DCE, and VCE. Our detection rates of neoplastic lesions were similar to other studies conducted for detection rates during surveillance in IBD ( 6 ) . Th e results were similar when sessile serrated adenoma lesions were not considered. Th erefore in this study, the fi nding support use of HD-WLE for IBD surveillance but multicener, multi-observer studies are required to confi rm these fi ndings.
In a retrospective observational study, Subramanian et al. ( 27 ) also found that dysplasia was discovered in approximately twice the number of patients undergoing HD colonoscopy compared with SD-WLE colonoscopy: the adjusted prevalence ratio was 2.2 (95% CI 1.1-4.5).
DCE is considered the standard of the care to increase detection rate of neoplasia in IBD patients. A recent meta-analysis of eight studies, which used the previous generation of SD-WLE endoscopes, revealed that DCE compared with SD-WLE signifi cantly increased the number of dysplastic lesions detected by almost twofold (RR=1.9; 95% CI 1.4-2.7) ( 6 ).
Mooiweer et al. ( 12 ) demonstrated that implementation of DCE for IBD surveillance in clinical practice did not increase dysplasia detection compared with WLE with targeted and random biopsies in a panelists had agreed ( 6 ) . Note that SD-WLE may still require random biopsies, even if targeted biopsies alone may be suffi cient for HD-WLE, DCE, and VCE, apart from a few biopsies to assess infl ammatory status. In our study, patients with active infl ammation in any colonic segment were not included in the study. Th erefore, in our clinical practice we preferred to perform surveillance colonoscopy in IBD patients using targeted biopsies. In our study, exploratory univariate and multivariate statistical model analysis of the colonic lesions detected and characterised by the three technologies were performed to predict clinical or endoscopic features predictive of colonic neoplasia in IBD patients (histology gold standard). Th e endoscopic Kudo pit pattern and localization of the lesions in the right colon were predictors of colonic neoplasia in IBD ( Tables 4 and 5 ). Sensitivity analysis by excluding sessile serrated adenoma lesions did not change the conclusions. Family history of colorectal cancer was not a predictor of the colorectal neoplasia.
Th e value of Kudo pit patterns to predict histology in IBD patients remains controversial especially when these lesions are assessed by using standard scopes without magnifi cation. Th e colonic mucosa of IBD patients might be distorted due to longstanding chronic infl ammation; furthermore, dye spraying may also obscure the Kudo pit pattern. Th e Kudo pit pattern can be assessed with the new generation HD with or without VCE and without magnifi cation, as in this study ( 32, 34, 35 ) . Th ough not the primary objective of this study, we do present our data in the context of this study on lesion characterisation, including the Kudo pit pattern. Th is is the fi rst support for using the Kudo pit pattern in neoplastic lesions characterisation in IBD surveillance. Further studies are required on lesion characterisation including usefulness of the Kudo pit pattern in the context of IBD.
In our study, there were a disproportionate number of primary sclerosing cholangitis patients in the HD group, as recruitment was not stratifi ed. However, only one low-grade dysplastic lesion was detected in a patient with ulcerative colitis-associated primary sclerosing cholangitis who underwent surveillance in the VCE group. Analyzing the results by excluding primary sclerosing cholangitis patients did not change the conclusions, with the limitation that it reduced the sample size in each arm. As only one low-grade dysplastic lesion was detected in a patient with ulcerative colitisassociated primary sclerosing cholangitis who underwent surveillance in the VCE group, the PSC-IBD group did not impact the results of this study but we had included these PSC patients as this is an important surveillance group.
A strength of our study is that it has been prospectively performed in a randomized fashion by an expert endoscopist trained on advanced technologies and IBD, as in procedural randomization, standardizing skills, learning curve, and experience may be confounding factors with multiple endoscopists. Having one expert endoscopist harmonized the cognitive elements of lesion detection and characterisation. Performing a three arm randomized study with back to back colonoscopies in a multi-operator, multicenter format is challenging and we hope our study will help plan further studies by choosing two rather than three techniques. We hope both single observer and multi observer studies will inform the debate as this is the second randomized study comparing diff erent techniques for surveillance colonoscopy in IBD. Th e operator (MI) had considerable experience with all three techniques, and the analysis of the data over quartiles of procedures did not show any increase in detection rates. Other studies such as recent study of mucosal healing endoscopic Mayo score 0 Vs 1 also involved a single experienced operator, Barreiro-de Acosta, who did all the endoscopies ( 36 ), to minimized the risk of inter-observer variability in assessment. More importantly, the pivotal paper on dye chromoendoscopy was done by a single operator, Dr M Rutter ( 37 ), However, we also acknowledge that this is also a limitation (e.g., would other operators see similar results?) and therefore multiple operators are recommended for future randomized trials. In addition, in future multicentre studies, skills, and learning curve with the three techniques should be harmonized by training modules to achieve acceptable inter-observer agreement or by central readout. Th is should also involve diff erent endoscopy platforms such as iSCAN (Pentax), NBI (Olympus, Tokyo, Japan), and BLI (Fujinon, Tokyo, Japan), but because of rapid advances in technology needs harmonized skills and latest generation scopes and processors. Th e three-arm single-operator study should be followed up by a two arm multicentre study with multiple operators and from the results of our study it would be rational to use HD-WLE and DCE. Kiesslich et al. ( 8 ) in the pivotal randomized trial establishing the use of methylene blue DCE used 1:1 randomization and not tandem colonoscopies; we followed a similar protocol in a 1:1:1 randomization as it is diffi cult to do tandem studies with a threearm design and patient acceptance of tandem colonoscopy may be limited. Similar to our study, the randomized dye Chromoendoscopy vs. white light Chromoendoscopy trial by Kiesslich et al. ( 8 ) the lesions were only detected on withdrawal.
Stratifi cation by primary sclerosing cholangitis or family history may also be relevant in future studies, although sensitivity analysis without these patients did not change the conclusion. Neither primary sclerosing cholangitis nor family history predicted neoplasia in multivariate analysis. Th ere was no apparent diff erence between ulcerative colitis and Crohn's colitis in detection rates, although the study was not powered to answer this question.
In conclusion, our randomized trial demonstrated that for experienced operators, virtual electronic chromoendoscopy or HD colonoscopy is not inferior to dye spraying colonoscopy for detection of colonic neoplastic lesions during surveillance colonoscopy. In fact, in this study HD colonoscopy alone was suffi cient for detection of dysplasia, adenocarcinoma or all neoplastic lesions. However, multicentre, multiple operator studies are required verify our conclusions. 
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